Rocaglamide ≥98% (durch HPLC)

Lieferant: ENZO LIFE SCIENCES

Synonyme: (1R,2R,3S,3aR,8bS)-1,8b-Dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-2-carboxamide

ALX350121C100
ENZOALX350121C100EA 646 EUR
ENZOALX350121C100
Rocaglamide ≥98% (durch HPLC)
Rocaglamide

NF-kappaB inhibitor


Immunosuppressant. Potent inhibitor of NF-kappaB activation in T cells, with an almost complete inhibition at 200nM. Suppresses cytokine production (IFN-gamma, TNF-alpha, IL-2 and IL-4) and inhibits NF-AT in peripheral blood T cells at concentrations that do not impair NF-kappaB and AP-1 activities. In contrast to the immunosuppressant cyclosporin A (Prod. No. BML-A195), rocaglamide does not inhibit calcineurin phosphatase activity. Induces apoptosis.


Isolated from Aglaia sp.

Formel: C₂₉H₃₁NO₇
Molecular Weight: 505.56 g/mol
MDL: MFCD08702699
CAS-Nummer: 84573-16-0

Bestellen


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Mehr About VWR